-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Links between testing, test results, and patient outcomes are complex. … Example: HIV testing
Direct effects: Emotional distress from the testing process, cognitive/emotional … For example, testing for HIV has both direct and indirect effects. … summary testing performance (e.g., sensitivity, specificity). … The table shown classifies the results of PET testing.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Links between testing, test results, and patient outcomes are complex. … Example: HIV testing
Direct effects: Emotional distress from the testing process, cognitive/emotional … For example, testing for HIV has both direct and indirect effects. … summary testing performance (e.g., sensitivity, specificity). … The table shown classifies the results of PET testing.
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
June 01, 2012 - Setting Who will use the prognostic test; how the test will be used; what the applicable testing scenario … Cost-effectiveness: Do the improvements in patient outcomes justify the additional costs of testing and … Were the subjects somehow referred or selected for testing? What was the testing scenario? … The second question asks about the subject selection and testing scenario. … Subpart A asks about uniformity of testing across all sites or all studies being reported.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
June 01, 2012 - Setting Who will use the prognostic test; how the test will be used; what the applicable testing scenario … Cost-effectiveness: Do the improvements in patient outcomes justify the additional costs of testing and … Were the subjects somehow referred or selected for testing? What was the testing scenario? … The second question asks about the subject selection and testing scenario. … Subpart A asks about uniformity of testing across all sites or all studies being reported.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
May 01, 2013 - We found two studies evaluating WMC as
an add-on to other testing. … Consensus guidelines suggest that WMC testing is a replacement for current testing methods,
however … The next series of questions asked about the incremental value of WMC testing in addition to
other testing … testing. … We found two studies evaluating WMC
as an add-on to other testing.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-2013
April 15, 2013 - Patients may request HIV testing in the absence of reported risk factors. … More information on HIV testing is available at www.cdc.gov/hiv/topics/testing/index.htm and https … ://www.fda.gov/patients/hiv-prevention/hiv-testing . … screening in order to reduce barriers to testing. … Adolescents and HIV infection: the pediatrician's role in promoting routine testing.
-
psnet.ahrq.gov/node/44346/psn-pdf
March 18, 2016 - Developing a primary care patient measure of safety (PC
PMOS): a modified Delphi process and face validity
testing … Developing a primary care patient measure of safety (PC PMOS): a
modified Delphi process and face validity testing … through a modified Delphi process
and was well received by patients and staff during face validity testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
September 01, 2013 - Genetic testing for CYP2C19
ii. … Genetic testing for CYP2C19 followed by
phenotypic testing for platelet reactivity
iii. … Phenotypic testing for platelet reactivity
iv. No testing
b. … Use
of phenotypic testing (but not genetic testing) as a
monitoring test can be considered a variation … Combined Testing for CYP2C19 Variants
and Phenotypic Testing To Guide Antiplatelet
Treatment
Of the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_executive.pdf
January 01, 2016 - Rapid Streptococcus Antigen Testing. … C-Reactive Protein Testing. … The combination of communication
training and CRP testing was not different from
CRP testing alone … +
Procalcitonin testing +
Rapid strep testing +
Combination of patient and provider education plus audit … training, communication training plus
CRP testing).
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/EWdKKL983qWHgW4zCjWtRV
Screening Tests Transvaginal ultrasonography and serum cancer antigen (CA)–125 testing are the most commonly … Balance of Benefits and Harms
Annual screening with transvaginal ultrasonography and serum CA-125 testing … Recommendations
The USPSTF has made a recommendation on genetic risk assessment and BRCA mutation testing
-
psnet.ahrq.gov/web-mm/pre-analytical-pitfalls-missing-and-mislabeled-specimens
April 18, 2018 - Upon arrival at the satellite facility, samples are logged and accessioned for testing at their respective … Modern laboratory testing incorporates numerous safeguards such as external and internal quality controls … Some facilities may incorporate robotics ( i.e., automation) to aid in the testing process to maximize … Medical testing error occurs most frequently during the pre-analytic phase. … Risk management in the preanalytical phase of laboratory testing.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/r7JMWkKKv2krN6cxKQUUfP
January 01, 2010 - Trials are underway that should soon clarify the role
of HPV testing in cervical cancer screening. … Liquid-based cytology permits testing
of specimens for HPV, which may be useful
in guiding management … Adding HPV testing to
conventional screening is unlikely to be worthwhile,
but HPV testing may have a … With regard to HPV testing, the USPSTF did
not identify any studies that quantified harms. … HPV testing in
primary screening of older women. Brit J Cancer.
1999;81(3):554–558.
20.
-
digital.ahrq.gov/sites/default/files/docs/publication/developmentmethodskeyinformantinterviewsreport.pdf
July 10, 2012 - Testing refers to the role of testing and evaluating the product during the design lifecycle. … questions that the testing might be
designed to answer. … • Using testing to inform a holistic assessment, future testing, or design changes. … techniques, formal
laboratory-based testing, and testing with individuals who were not current customers … • Testing takes place throughout the design process.
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs021733-sheehan-final-report-2014.pdf
January 01, 2014 - the limits of accuracy of body tracking by the IBEHR, and then perform beta testing to verify
that … Alpha testing revealed gross
inaccuracy in tracking lower extremity exercise. … • Perform alpha and beta testing. … PERFORM ALPHA AND BETA TESTING. … Beta Testing: The IBEHR user interface was tested by the PT (Mr.
-
psnet.ahrq.gov/node/43865/psn-pdf
May 01, 2015 - Computerised physician order entry-related medication
errors: analysis of reported errors and vulnerability
testing … Computerised physician order entry-related medication errors:
analysis of reported errors and vulnerability testing … findings mirror those of a prior
simulation study and highlight the importance of real-world usability testing
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/cervical-cancer-screening
August 21, 2018 - First-round colposcopy rates were also higher, ranging 1.2% to 7.9% for primary hrHPV testing, compared … What is the effectiveness of hrHPV testing, with or without cytology, as a primary screening strategy … No trials compared hrHPV primary testing with cotesting. … Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial … ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
-
effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
January 01, 2009 - Premature dissemination of testing technologies can lead
to erroneous diagnoses and preventable delays … The ultimate question in
decisions about testing is how much net gain from testing there will be for … The benefits from testing may be limited to a subset of those tested, so sample size
requirements can … be substantial.45 Trials of testing need a well-defined protocol that links testing,
results, and downstream … All of these practical problems
are challenging but not insurmountable, and trials of testing can be
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017075-sequist-final-report-2010.pdf
January 01, 2010 - administration of
aspirin therapy for high risk patients (FRS > 10%); and avoidance of cardiac stress testing … The survey instrument underwent cognitive testing on
a convenience sample of 5 primary-care physicians … Current guidelines recommend against
the use of such testing for low risk patients based on the poor … Prior studies
of decision support have focused on reducing unnecessary testing represented by avoiding … outset, such as exercise testing in low risk patients.
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year3-final-report-2019.pdf
January 01, 2019 - and testing. … CQL
Services and the CQL Testing Framework should also be updated to support testing and
executing … Update the CQL Testing Framework to support all FHIR resource types: Currently,
the CQL Testing Framework … Key work products: Alpha, beta, and production-level prototype tool (CQL
Testing Framework); CQL Testing … AHRQ-CDS/CQL Testing Framework. https://github.com/AHRQ-CDS/CQL-
Testing-Framework.
-
cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
January 01, 2012 - Healthy Weight
Stage 1:
Freehand mockup
Stage 2
Wireframe mockup
Stage 3
Interactive module
Stage 4
User testing … Stage 1
Quick, easy, low overhead, adaptable
Stage 2
Layout, spacing, internal workflow (white box testing … Testing before implementation
Everything functions as expected
Patient data is appropriately handled … The CDS does not break the EHR
Testing after implementation
How do different clinical workflows impact … is possible
Even minimally tested CDS can have an immediate impact on patient care, but inadequate testing